Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Norbrook Laboratories Ltd issues recall of anaesthetic
product recall
The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).
Coring issue reported for Propofol Emulsion for injection
 
Wholesalers and veterinary surgeons are being made aware of a product defect recall for Propofol Emulsion for Injection, which is manufactured by Norbrook Laboratories Ltd.

All batches of Propofol Emulsion for Injection 1.0% w/v that are currently on the market are being recalled, due to an issue of coring.

In a statement, the Veterinary Medicines Directorate (VMD) said: ‘An issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product and potentially being drawn up into the syringe upon extraction of the product from the vial. It may also result in the bung not resealing fully after use.’

The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).

For further information contact Mrs Deborah Curran on 028 3026 4435 or email deborah.curran@norbrook.co.uk

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.